The local Streptomyces sp. strain showed an ability to produce antimicrobial metabolite active against standard strains, in primary and secondary screening. The produced antibiotic was extracted, purified and identified as a peptide antibiotic produced about 1.4g/L in 7 days incubation period, and its LD 50 was 5500.
INTRODUCTION
Most antibiotics have been isolated from cultures of bacteria particularly Actinomycetes, fungi, algae, higher plant, lower and higher animals, they were used as antibacterial, antifungal, antiviral, antiprotozoal, antialgal, antihelminthic, insecticidal, herbicidal, cytotoxic and anticancer antibiotic 1 . But, the major part of microorganisms that can produce antibiotics inhabits in the soil 2 .Majority of antibiotics produce by Actinomycetes belong to genus Streptomyces 3 .
Actinomycetes produce approximately two-thirds of all known antibiotic of microbial origin, including over 6000 different chemical structures 4 .
The emergence of multiply antibiotics-resistance human pathogens has resulted in an urgent need for new antibiotics,investigators search for new more efficacious preparations produced by various groups of organisms 4 .
The aims of the present study.
1. Isolation and purification of antibiotic produced by local isolate of Streptomyces sp..
Improvement of antibiotic production by
Escherichia coli pBR322 transformation.
MATERIALS AND METHODS
The Test Organisms:
Standard Strains :Include the following microorganisms:-
Bacillus subtilis (PCI 219),Escherichia coli (NCTC 5933),E. coli (pBR 322),Klebsiella pneumoniae (ATCC 10031),Pseudomonas aeruginosa (NCTC 6750),Staphylococcus aureus (NCTC 6571), they were received from biotechnology lab., biology department, college of science, Basrah university .
Local Clinical Isolate (clinical strain)
Staphylococcus aureus, received from bacteriology lab., biology department, college of science, Basrah university.
Antibiotic Producer Strain:
Streptomyces sp.
5
Culture Media:
1.Commercial media: including, Actienomyces Isolation Agar , Antibiotics medium base,
Mueller hinton agar, Nutrient agar, Trypton soy broth and Yeast malt extract. All media were prepared as recommended by the manufacturing company (Difico), sterilized by autoclaving 121°C for 15 min, cooled to 50°C and poured into Petri dishes.
Prepared media
1. Activation medium:It was prepared according to 6, 7 .
Seed Media:
It was prepared according to 8 .
3. Fermentation medium it was prepared according to 9 .
4. Luria-Bertani broth:It was prepared according to 10 5. Luria-Bertani agar:It was prepared according to 10 Activation of Streptomyces sp. Bacteria:
The activation of Streptomyces sp. Performed according to the method of 6,7. Preparation of Spores Suspension:
The spores suspension of the isolate was prepared according to 11 .
Preservation of the Recovered Isolate:
Spores suspension was stored according to 12 .
Primary Screening of Antibiotic Activity for Streptomyces sp.:
The primary screening was carried out according to 13 . 15 .
Determination of Antibiotic Production by
Extraction and Purification of the Produced Antibiotic in Fermentation Media:
Extraction and Purification of produced antibiotic was performed according to method describe by 16 .
Identification
The producer antibiotic was identify according to 17 Determination of LD 50 :
The LD 50 of extracted antibiotic was studied with male mice type (Albino), mice were divided into 5 groups, 8 mice in each group, one of them used as control, all control group mice were injected intraperitoneally by 0.25 ml D.W. other mice in all groups were injected intraperitoneally by 0.25 ml antibiotic solution in different concentration (3000, 4000, 5000 and 6000) ml/kg, all animal were examined for 3 days, the results were analysed according to probate analysis method described by 23 .
Plasmid Curing from Streptomyces sp.:
Curing experiments were performed by using acridine orange as curing agents according to 4 .
Determination of Antibiotic Activity of Curing Cells:
To determine the colonies that lost the antimicrobial activity after treatement with acridine orange. All growing colonies which appeared at 28 g/ml concentration after 7 days incubation were inoculated on Petri dishes containing AIA and incubated at 28°C for 7 days 34 , then plug method describe by 13 were used.
Extraction of Plasmid DNA:
Plasmids DNA were extracted from Streptomyces sp. bacteria according to method describe 25 .
Agarose gel electrophoresis:
DNA samples were loaded on 1% agarose gel and run in TBE buffer (89mM tris base, 89mM boric acid and 2mM EDTA, pH adjusted to 8) at 4V/cm, and stained with ethedium bromide, DNA bands were visualized by UV illumination at 340nm 25 .
Primary Screening of Escherichia coli pBR322:
E. coli pBR322 was screened for antibiotic production according to plug method 13 .
Preparation of Competent Cells of Escherichia coli pBR 322:
Competent cell were prepared according to 10 .
Plasmid DNA Transformation:
Method described by 10 was carried out to plasmid DNA transformation.Determination of Transformed Cells Escherichia coli pBR322To determinate the trans. E. coli pBR322, the method of (Hotta et al ) 26 . was used and the plug method described by (Tyler et al) 13 was used to determine which colonies producing antibiotic. Extraction and Purification of Antibiotic Produced by Transformed Escherichia coli pBR322:
The methods described in previous stepes were used for extraction, purification and identification of the antibiotic produced by trans. E. coli pBR322. Then compare with antibiotic produced by S. sp.
Testing Transformed Escherichia coli pBR322 Ability to Retain Antibiotic Production
After preservation period for 6 months the antibiotic was produced by trans. E. coli in F.M. at the same incubation conditions, and then extracted, purified and identified by the same methods mentioned above
RESULTS

Screening of Antibiotic Activity for Streptomyces sp., Escherichia coli pBR322 and Transformed
Escherichia coli pBR322.
Primary Screening:
The antibiotic activity of S. sp., E. coli pBR322 and trans. E. coli pBR 322 were tested against the standard strains.The size of growth inhibition zone vary with theses microorganisms,(table1).The results of antibiotic activity of E. coli pBR 322 against the standard strains was negative, which means that the E. coli pBR 322 before transformation did not able to produce any biological active metabolites, while trans. E. coli pBR 322 showed a positive results( table1). The LD 50 of the produced antibiotic by S. sp. and trans E. coli pBR322 showed an identical result (5500) mg/kg, figs. (1and 2).
Plasmid curing: Fig. (3) showed an inverse effect for orange acridin dye concentration with the growth colonies number of S. sp. bacteria, the percentage of growing colonies was 28%, 5% and 0.4% when the dye was added in the concentration of 24, 28 and 32 g/ml respectively. The 28 g/ml dye 
Estimation of Antibiotic Production Ability after Preservation Period
Trans. E. coli pBR322 has produced an equal amount of antibiotic after the preservation period and demonstrated the same diagnostic tests and biological properties Fig. (5) . 
Preparation of Competent Cells:
The nonspecific acceptance of small soluble DNA fragment from the surrounding environment by a bacterial cell is termed transformation. Cells that are capable of accepting genetic material through this means are termed competent 28 . Competency of E. coli can be induced in this study by treatment with calcium chloride in the early lag phase of growth. The bacterial membrane is permeable to chloride ion but is non-permeable to calcium ions. As the Antibiotic production (g/l)
chloride ions enter to the cell water molecule accompany the charged particle. The influx of water causes the cell swell and is necessary for the uptake of the DNA 28 . Also calcium chloride induces structural alteration in the bacterial cell walls which help in the binding of DNA with cell wall and facilitate cell transformation 29 .
Transformation: According to the ability of some E. coli pBR322 after plasmid DNA transformation to inhibit the growth of standard strains of Gram positive and Gram negative bacteria which was unable to inhibit them before transformation, we can say that the transformed E. coli pBR322 have the ability to accept a foreign plasmid DNA and express it, as antibiotic formation and production. These results are in agreement with 30 , who reported that, the expression of S. genes coding for antibiotic biosynthesis in E. coli appears to occur, and with 31 ; 32 , who reported that genes coding for antibiotic biosynthesis appear to be clustered on the plasmid DNA of antibiotic produces in Streptomyces bacteria.
Not all E. coli pBR322 were transformed with plasmid DNA, this result is in agreement with 29 ; 28 , who reported that not all bacterial cells have been transformed with the plasmid and the potential for the plasmid not to propagate itself in all daughter cell. Therefore it is necessary to select bacterial cells that contain the plasmid. This is commonly performed using antibiotic selection. Marker genes can be used to determine if the gene has been taken up. Must they have some distinguishable characteristic for example antibiotic resistance 33 . In the present study antibiotic production genes was used as the marker genes for determination the transformed bacteria depending on growth inhibition activity against the test microorganisms.
In addition to the antibiotic production activity the trans. E. coli pBR322 acquired the resistance ability to the produced antibiotic, this result is in agreement with 34 , who reported that the transfer of 60 kb conjugative plasmid pEJ97 from the bacteriocinogenic strain Enterococcus faecalis (EJ97) to E. faecalis (OG1X) conferred bacteriocin production and resistance on the recipient. This biological activity may be due to the resistance genes for the produced antibiotic which is found together with antibiotic production genes on the same plasmid. This result is in agreement with other studies as the study of 35 , who reported that, the methylenomycin biosynthetic genes (mmy) found together with a resistance determinant (mmr), are all carried on large liner plasmid SCP1 in Streptomyces coelicolor A3 (2) , and the study of 35 , who reported that a 70 kb liner plasmid pSV2 in S. violaceoruber SANK 95570 appeared not to be involved in methylenomycin production because (mmr) gene did not hybridize to it in spit of this plasmid carried the methylenomycin production genes (mmy), also the present results are in agreement with 36 , result who detected the pSV1 plasmid by agarose gel electrophoresis and implicated it in methylenomycin production by its hybridization to the methylenomycin resistance (mmr) gene.
In comparative between the amount of the produced antibiotic by the two microorganisms S.
sp. and transformed E. coli pBR322 we can notice the increase in antibiotic production by last bacteria in the same fermentation medium (F.M.III), 2.2 g/l during shorter period of time (2 days only), while 7 days are needed to produce 1.4 g/l in case of S. sp.. Therefore we can produce 7.7 g/l antibiotic by transformed E. coli pBR322 during the same period of time, these results are in agreement with 30 , who reported that, the increasing antibiotic production by amplification of the genes coding for limiting enzymes in the biosynthetic pathways is possible, and it is an economic and commercial method to antibiotic production in a shorter time and same substrate (F. M.). 
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